JP2008512399A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512399A5
JP2008512399A5 JP2007530572A JP2007530572A JP2008512399A5 JP 2008512399 A5 JP2008512399 A5 JP 2008512399A5 JP 2007530572 A JP2007530572 A JP 2007530572A JP 2007530572 A JP2007530572 A JP 2007530572A JP 2008512399 A5 JP2008512399 A5 JP 2008512399A5
Authority
JP
Japan
Prior art keywords
enzyme
pharmaceutical composition
composition according
arginase
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512399A (ja
Filing date
Publication date
Priority claimed from CNA2004100768544A external-priority patent/CN1745847A/zh
Application filed filed Critical
Publication of JP2008512399A publication Critical patent/JP2008512399A/ja
Publication of JP2008512399A5 publication Critical patent/JP2008512399A5/ja
Pending legal-status Critical Current

Links

JP2007530572A 2004-09-08 2005-09-06 医薬組成物およびアルギナーゼを用いる肝炎の処置方法 Pending JP2008512399A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2004100768544A CN1745847A (zh) 2004-09-08 2004-09-08 用精氨酸酶治疗肝炎的药物组合物和方法
PCT/CN2005/001411 WO2006026915A1 (fr) 2004-09-08 2005-09-06 Composition pharmaceutique et methode de traitement de l'hepatite avec des arginases

Publications (2)

Publication Number Publication Date
JP2008512399A JP2008512399A (ja) 2008-04-24
JP2008512399A5 true JP2008512399A5 (cg-RX-API-DMAC7.html) 2008-10-02

Family

ID=36036072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530572A Pending JP2008512399A (ja) 2004-09-08 2005-09-06 医薬組成物およびアルギナーゼを用いる肝炎の処置方法

Country Status (6)

Country Link
US (1) US20080299638A1 (cg-RX-API-DMAC7.html)
EP (1) EP1803465A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008512399A (cg-RX-API-DMAC7.html)
KR (1) KR20070100875A (cg-RX-API-DMAC7.html)
CN (1) CN1745847A (cg-RX-API-DMAC7.html)
WO (1) WO2006026915A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3064579T3 (pl) 2008-10-31 2021-07-05 Aerase, Inc. Kompozycje farmaceutyczne i zastosowania medyczne uzyskanych metodami inżynierii ludzkich arginaz
AU2010242422B2 (en) 2009-03-26 2014-12-04 The Hong Kong Polytechnic University Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
CN103184209B (zh) 2011-12-27 2015-09-16 拜奥生物科技(上海)有限公司 人精氨酸酶和聚乙二醇化人精氨酸酶及其应用
EP3137103B1 (en) 2014-04-29 2021-10-20 Bio-Cancer Treatment International Ltd. Methods and compositions for modulating the immune system with arginase i
ES2909556T3 (es) 2016-08-08 2022-05-09 Aerase Inc Composiciones y procedimientos para el tratamiento de cáncer con agentes de disminución de arginina y de inmunoncología
TWI878212B (zh) 2017-12-05 2025-04-01 瑞典商伊梅爾迪卡製藥公司 用於治療精胺酸酶1缺乏症之方法及組合物
WO2020081994A1 (en) 2018-10-19 2020-04-23 Aerase, Inc. Arginine depletion therapy for treatment of gamt deficiency
BR112022003633A2 (pt) 2019-08-30 2022-06-07 Aeglea Biotherapeutics Inc Métodos para produção de arginase 1 recombinante humana e usos da mesma
TW202200210A (zh) * 2020-04-17 2022-01-01 香港商康達醫藥科技有限公司 使用精胺酸酶治療病毒感染之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1059127C (zh) * 1995-07-19 2000-12-06 郝文学 治疗肝病的药物“疏肝酶”的制法
US5780286A (en) * 1996-03-14 1998-07-14 Smithkline Beecham Corporation Arginase II
US5851985A (en) * 1996-08-16 1998-12-22 Tepic; Slobodan Treatment of tumors by arginine deprivation
US6183738B1 (en) * 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
RU2335539C2 (ru) * 2002-06-20 2008-10-10 Байо-Кэнсер Тритмент Интернэшнл Лимитид Фармацевтический препарат и способ лечения злокачественных опухолей у человека с помощью аргининовой депривации
HK1053577A2 (en) * 2002-06-20 2003-10-10 Bio-Cancer Treatment International Limited Pharmaceutical composition and method of treatment of human malignanices with arginine deprivation

Similar Documents

Publication Publication Date Title
US7201897B2 (en) Interferon conjugates
ES2303361T3 (es) Conjugados de interferon-alfa-polimero con actividad biologica potenciada y procedimientos de preparacion de los mismos.
EP0981607B1 (en) Modified arginine deiminase
JP5746137B2 (ja) アルギナーゼの部位指定的ペグ化並びにその抗がん剤及び抗ウイルス剤としての使用
ES2207830T3 (es) Conjugados de polietilenglicol-interferon alfa para la terapia de infecciones.
JP2012521201A5 (cg-RX-API-DMAC7.html)
WO2002044360A2 (en) Modified arginine deiminase
CN103228792A (zh) PEG-干扰素λ1结合物
CN1655812A (zh) 抗微生物聚合物轭合物
CN102453089B (zh) 重组集成干扰素变异体聚乙二醇偶联物的制备和应用
JP5613050B2 (ja) タンパク質−高分子結合体
RU2005101076A (ru) Фармацевтический препарат и способ лечения злокачественных опухолей у человека с помощью аргининовой депривации
Lollo et al. Gene therapy strategies for the treatment of chronic viral hepatitis
WO2006026915A1 (fr) Composition pharmaceutique et methode de traitement de l'hepatite avec des arginases
JP5798628B2 (ja) ウシ顆粒球コロニー刺激因子のための製剤およびその変異体
JP5639585B2 (ja) ペプチド−ポリマー共役体
CN102724980B (zh) 蛋白-聚合物偶联物的治疗用途
CN101612388A (zh) 一种猪用α-干扰素高效注射液及其制备方法